BioAge Labs, Inc.

Historical 13F Holders

Symbol
BIOA
CUSIP
09077V100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09077V100 since 12/18/2024, largest first.

Filer % of Class Filed
Kristen Fortney 13G/A 7.2% 2/13/2026
Event 12/31/2025
Cormorant Asset Management, LP 13G/A
5.4% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G 5.0% 4/27/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Khosla Ventures VI, L.P. 13G/A
4.0% 5/15/2026
Event 5/15/2026
RA Capital Management, L.P. 13G/A
3.7% 2/14/2025
Event 12/31/2024
ADAR1 Capital Management, LLC 13G/A
0.4% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 313 $2.22 k
2026 Q2 163 37.7 M $925 M
2026 Q1 152 34.7 M $606 M
2025 Q4 119 23.7 M $315 M
2025 Q3 101 21.4 M $126 M
2025 Q2 88 20.8 M $86.0 M
2025 Q1 69 20.3 M $76.2 M
2024 Q4 66 19.6 M $114 M
2024 Q3 60 20.9 M $435 M